CLARIVATE PLC (CLVT): Results of Operations and Financial Condition
CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026earningsrelease.htm EX-99.1 Ex. 99.1 Q2 2026 Earnings Release 1 Clarivate Reports Second Quarter 2026 Results — Delivers continued progress on strategic and financial priorities through Value Creation Plan — — Sharpens focus and enhances financial profile wit
How this was made
The 30-second read
Why it matters
Q2 shows lower total and organic revenues, but organic ACV growth and recurring revenue stability, alongside meaningful deleveraging and reaffirmed full-year targets for ACV growth, recurring revenue growth, adjusted EBITDA, adjusted EPS, and free cash flow.
Market read
Traders can update models using the provided Q2 datapoints and the explicit 2026 guidance ranges, especially around recurring growth and free cash flow.
What to watch
Investors may underweight the magnitude of debt reduction and the specific drivers of subscription vs transactional trends (product group wind-downs and customer migrations to subscription offerings).
Background
Clarivate’s Value Creation Plan is paired with a previously announced Life Sciences & Healthcare segment divestiture and a shift toward a more subscription-led revenue base.
Ticker impact
Clarivate reports Q2 2026 results, including a $221.7M non-cash goodwill impairment and reaffirmed 2026 outlook after a Life Sciences & Healthcare divestiture.
Likely choppy reaction: investors may focus on organic revenue softness and impairment, offset by reaffirmed ACV/recurring growth and free-cash-flow range.
The filing provides concrete datapoints (revenue decline, organic trends, impairment, FCF, debt reduction) and explicit 2026 ranges, but no new deal terms beyond previously announced divestiture.
Market effects
Signals ongoing subscription-led revenue transition and cost discipline in enterprise intelligence/software, with divestiture-driven portfolio reshaping.
Limited direct regional read-through; Clarivate’s global revenue base makes the impact more company-specific than country-specific.
May influence sentiment toward other knowledge-intelligence and research-software peers that are also shifting toward recurring revenue and deleveraging.
Counterpoint
The impairment-driven GAAP loss may be less informative than cash generation, but the organic revenue decline and transactional weakness could indicate demand softness that guidance may not fully capture.
Key entities
- issuerClarivate Plc
Reports Q2 2026 results, impairment, cash flow, and reaffirmed 2026 outlook tied to its Value Creation Plan and divestiture focus.
